We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

346 hedge funds and large institutions have $7.99B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 120 increasing their positions, 112 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 112

2% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 94

1% less funds holding

Funds holding: 348 → 346 (-2)

24% less capital invested

Capital invested by funds: $10.6B → $7.99B (-$2.57B)

26% less funds holding in top 10

Funds holding in top 10: 19 → 14 (-5)

41% less call options, than puts

Call options by funds: $231M | Put options by funds: $389M

Holders
346
Holders Change
-2
Holders Change %
-0.57%
% of All Funds
9.23%
Holding in Top 10
14
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-26.32%
% of All Funds
0.37%
New
96
Increased
120
Reduced
112
Closed
94
Calls
$231M
Puts
$389M
Net Calls
-$158M
Net Calls Change
-$27.2M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$703M
2
JHIU
Janus Henderson Investors US
Colorado
+$181M
3
Morgan Stanley
Morgan Stanley
New York
+$156M
4
O
OppenheimerFunds
New York
+$143M
5
Invesco
Invesco
Georgia
+$109M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$496M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$489M
3
TCIM
TIAA CREF Investment Management
New York
-$159M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$119M
5
Citadel Advisors
Citadel Advisors
Florida
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
176
Ghost Tree Capital
New York
$3.45M +$3.63M +30,000 New
TD Asset Management
177
TD Asset Management
Ontario, Canada
$3.45M +$3.63M +30,000 New
AQR Capital Management
178
AQR Capital Management
Connecticut
$3.35M -$1.04M -8,600 -23%
NIP
179
Nicholas Investment Partners
California
$3.3M -$614K -5,070 -15%
Bank of Montreal
180
Bank of Montreal
Ontario, Canada
$3.16M +$298K +2,460 +10%
N
181
Nuveen
North Carolina
$2.99M -$1.94K -16 -0.1%
EAM
182
EULAV Asset Management
Florida
$2.87M +$3.03M +25,000 New
HCM
183
Highbridge Capital Management
New York
$2.83M -$4.12M -34,029 -58%
CM
184
Castleark Management
Illinois
$2.81M -$7.05M -58,174 -70%
CSS
185
Cubist Systematic Strategies
Connecticut
$2.76M +$2.49M +20,547 +587%
GOCM
186
Green Owl Capital Management
New York
$2.76M +$2.91M +24,000 New
EA
187
Emerald Advisers
Pennsylvania
$2.74M +$2.89M +23,846 New
BACM
188
Blue Arrow Capital Management
New York
$2.64M +$2.79M +23,000 New
Walleye Trading
189
Walleye Trading
New York
$2.62M +$2.76M +22,779 New
OPERF
190
Oregon Public Employees Retirement Fund
Oregon
$2.59M +$460K +3,800 +20%
MERSOM
191
Municipal Employees' Retirement System of Michigan
Michigan
$2.38M +$323K +2,670 +15%
CI
192
Cowen Inc
New York
$2.37M -$7.9M -65,250 -76%
LMGAM
193
Liberty Mutual Group Asset Management
Massachusetts
$2.36M -$25.3K -209 -1%
ACI
194
AMP Capital Investors
Australia
$2.33M +$1.66M +13,688 +216%
EAM
195
EverPoint Asset Management
Connecticut
$2.3M +$606K +5,000 +33%
IGIM
196
I.G. Investment Management
Manitoba, Canada
$2.27M +$677K +5,590 +40%
FAF
197
Fjarde Ap-fonden
Sweden
$2.23M +$2.35M +19,409 New
ECM
198
Endurant Capital Management
California
$2.19M +$2.31M +19,100 New
DCM
199
Driehaus Capital Management
Illinois
$2.12M +$2.24M +18,473 New
BF
200
BOK Financial
Oklahoma
$2.12M -$352K -2,904 -14%
6 7
8
9 10

SLXP Hedge Fund Activity: Q4 2014 in Review

346 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2014, worth a combined $7.99B — down 24% from $10.6B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new SLXP positions and 94 closed out — a net gain of 2 holders — while 120 added to existing stakes and 112 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $496M.

  • 346 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2014, down from 348 in Q3 2014.
  • Funds reported $7.99B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2014, down 24% quarter-over-quarter.
  • 96 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2014 and 94 closed out, a net change of +2 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2014 was Paulson & Co, an estimated $703M added.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2014 was Wellington Management Group, an estimated $496M sold.

Based on aggregated 13F filings for Q4 2014.